Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

In vivo dendritic cell reprogramming for cancer immunotherapy
Ervin Ascic, Fritiof Åkerström, M. Nair, et al.
Science (2024) Vol. 386, Iss. 6719
Open Access | Times Cited: 20
Cross-priming in cancer immunology and immunotherapy
Carlos Luri‐Rey, Álvaro Teijeira, Stefanie K. Wculek, et al.
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 3
The regulatory role of integrin in gastric cancer tumor microenvironment and drug resistance
Songlin Wu, Abdel Nasser B. Singab, Guimei LlN, et al.
Progress in Biophysics and Molecular Biology (2025)
Closed Access | Times Cited: 2
Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis
Yuze Wu, Yuheng Yan, Yarong Guo, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti‐PD‐1/PD‐L1 cancer immunotherapy
Li Yu, Ke Huang, Yixiang Liao, et al.
Cell Proliferation (2024) Vol. 57, Iss. 8
Open Access | Times Cited: 13
Stimuli-Responsive mRNA Vaccines to Induce Robust CD8+ T Cell Response via ROS-Mediated Innate Immunity Boosting
Linying Dong, Xuqian Deng, Yan Li, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 28, pp. 19218-19228
Closed Access | Times Cited: 9
Tetrandrine activates STING/TBK1/IRF3 pathway to potentiate anti-PD-1 immunotherapy efficacy in non-small cell lung cancer
Yan Zhi Tan, Qiancheng Zhu, Meilin Yang, et al.
Pharmacological Research (2024) Vol. 207, pp. 107314-107314
Open Access | Times Cited: 9
Dendritic cell subsets and implications for cancer immunotherapy
Michael Y. Chen, Felicia Zhang, S. Peter Goedegebuure, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
CXCL14 in prostate cancer: complex interactions in the tumor microenvironment and future prospects
Lei Tang, Xin Chen, Jianquan Hou, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Interplay between extracellular vesicles and allergic diseases: Current insights and future perspectives
Jia Wu, Yan Wang, Yuqing Wang, et al.
Deleted Journal (2025)
Open Access | Times Cited: 1
Predictive circulating biomarkers of the response to anti‐PD‐1 immunotherapy in advanced HER2 negative breast cancer
Yuhan Wei, Hewei Ge, Yalong Qi, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access | Times Cited: 1
Engineering innate immune cells for cancer immunotherapy
Mubin Tarannum, Xizhong Ding, Marta Barisa, et al.
Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 516-533
Closed Access | Times Cited: 1
Cleavage of Homonuclear Chalcogen‐Chalcogen Bonds in a Hybrid Platform in Response to X‐Ray Radiation Potentiates Tumor Radiochemotherapy
Yuanyuan You, Yanzhou Chang, Shuya Pan, et al.
Angewandte Chemie International Edition (2024) Vol. 64, Iss. 1
Open Access | Times Cited: 7
Exploring the role of the immune microenvironment in hepatocellular carcinoma: Implications for immunotherapy and drug resistance
Yumin Fu, Xinyu Guo, Linmao Sun, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 5
The current role of dendritic cells in the progression and treatment of colorectal cancer
Yuanci Zhang, Songtao Ji, Ge Miao, et al.
Cancer Biology and Medicine (2024), pp. 1-15
Open Access | Times Cited: 5
Tertiary lymphoid structure formation induced by LIGHT-engineered and photosensitive nanoparticles-decorated bacteria enhances immune response against colorectal cancer
Lijun Hu, Li Tan, Shaohui Deng, et al.
Biomaterials (2024) Vol. 314, pp. 122846-122846
Closed Access | Times Cited: 5
The missing link between cancer stem cells and immunotherapy
Lobna Safwat Ali, Youssef Attia, Sohaila Mourad, et al.
Current Medical Research and Opinion (2024), pp. 1-35
Closed Access | Times Cited: 5
Turning cold into hot: emerging strategies to fire up the tumor microenvironment
Kejing Ma, Lin Wang, Wenhui Li, et al.
Trends in cancer (2024)
Closed Access | Times Cited: 5
From antigen uptake to immune modulation: the multifaceted potential of peptide nanofibers as vaccine nanocarriers
Hatem A. F. M. Hassan, Mohamed Haider, Sherif Ashraf Fahmy
Materials Advances (2024) Vol. 5, Iss. 10, pp. 4112-4130
Open Access | Times Cited: 4
Cleavage of Homonuclear Chalcogen‐Chalcogen Bonds in a Hybrid Platform in Response to X‐Ray Radiation Potentiates Tumor Radiochemotherapy
Yuanyuan You, Yanzhou Chang, Shuya Pan, et al.
Angewandte Chemie (2024) Vol. 137, Iss. 1
Open Access | Times Cited: 4
Fullerene‐Based Immunoregulatory Nanomaterials for Immunotherapy of Tumor and Immune‐Related Inflammatory Diseases
Mingming Zhen, Yuan Xu, Chunru Wang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 49
Open Access | Times Cited: 4
Oncolytic virus and tumor-associated macrophage interactions in cancer immunotherapy
Marc Lecoultre, Paul R. Walker, Aya El Helali
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Immunobiology of primary sclerosing cholangitis
Martin Cornillet, Daniel Geanon, Annika Bergquist, et al.
Hepatology (2024)
Closed Access | Times Cited: 4
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes
Yikan Sun, Eloy Yinwang, Shengdong Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth
Joanna Bandola-Simon, Yoshinaga Ito, Kai W. Wucherpfennig, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115150-115150
Open Access
Page 1 - Next Page

Scroll to top